Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Northeast Ethiopia
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20150026Keywords:
Artemether/lumefantrine, Plasmodium falciparum malaria, Efficacy, EthiopiaAbstract
Background: The impact of resistance to antimalarials is insidious and unless efficacy studies are conducted, resistance may go unrecognized. The aim of this study was to assess the efficacy of artemether/lumefantrine, for the treatment of uncomplicated Plasmodium falciparum infections in Kemisie Health Center, Northeast Ethiopia.
Methods: Artemether/lumefantrine efficacy study was conducted in Kemisie Health Center, Northeast Ethiopia from September, 2012 to May, 2013. The study participants were febrile people above the age of 6 months with confirmed uncomplicated P. falciparum infection. Patients were treated with artemether/lumefantrine. Clinical and parasitological parameters were monitored over a 28 days follow-up period to evaluate drug efficacy. The Kaplan–Meier method was used for statistical analysis of data on drug efficacy.
Results: Among the 66 enrolled participants 72.7% were 15 and above years of age while 15.3% were less than 5 years old. Of these study participants, 53% were male. There was 89.4% fever clearance and 84.8% parasite clearance on day 1, whereas, there was 100% fever clearance and 96.8% parasite clearance on day 3 from the 62 participants who carried on the study. Among 66 participants who had started 28 days of follow-up one patient had an early parasitological failure (parasitemia on day 3) and another patient had a late parasitological failure (parasitemia on day 21).
Conclusions: In general, this study discovered good clinical and parasitological response of P. falciparum to artemether/lumefantrine. Further polymeric chain reaction and plasma drug concentration based effectiveness study of artemether/lumefantrine should be conducted throughout the country.
Metrics
References
Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Trop. 1994;56(2-3):143-56.
FMOH (Federal Republic Ethiopia, Ministry of Health). Malaria diagnosis and treatment a guideline for health workers in Ethiopia. Addis Ababa: FMOH; 2004.
Haque R, Thriemer K, Wang Z, Sato K, Wagatsuma Y, Salam MA, et al. Short report: therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated plasmodium falciparum malaria in Bangladesh. Am J Trop Med Hyg. 2007;76(1):39-41.
WHO. Guidelines for the Treatment of Malaria. Geneva: World Health Organization; 2006.
Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361(5):455-67.
Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, et al. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359(24):2619-20.
Assefa A, Kassa M, Tadese G, Mohamed H, Animut A, Mengesha T. Therapeutic efficacy of Artemether/Lumefantrine (Coartem(R)) against Plasmodium falciparum in Kersa, South West Ethiopia. Parasit Vectors. 2010;3(1):1.
WHO. Guidelines for the Treatment of Malaria. 2nd Edition Geneva: World Health Organization; 2010.
WHO. Methods for Surveillance of Antimalarial Drug Efficacy. Geneva: World Health Organization; 2009.
Hwang J, Alemayehu BH, Hoos D, Melaku Z, Tekleyohannes SG, Teshi T, et al. In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia. Malar J. 2011;10:209.
Mulenga M, VangGeertruyden JP, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, et al. Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. Malar J. 2006;5:73.
WHO. Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000-2010. Geneva: World Health Organization; 2010.
Downloads
Published
How to Cite
Issue
Section
